Cell Death Dis:ASPP1缺乏促进结直肠癌侵袭和转移进展

2020-04-21 QQY MedSci原创

p53凋亡刺激蛋白(ASPP)家族由三个成员(ASPP1,ASPP2和iASPP)组成,三个成员的C末端序列相似,包括锚蛋白重复序列??、SH3结构域及富含脯氨酸的区域。在功能上,ASPP与凋亡调节蛋

p53凋亡刺激蛋白(ASPP)家族由三个成员(ASPP1,ASPP2和iASPP)组成,三个成员的C末端序列相似,包括锚蛋白重复序列??、SH3结构域及富含脯氨酸的区域。在功能上,ASPP与凋亡调节蛋白(包括p53、p63和p73)结合,调节细胞凋亡反应。

既往研究发现ASPP家族还与其他多种生物学过程相关,包括自噬、RAS诱导的衰老、妊娠滋养层细胞疾病及癌症的发生发展。

前期研究表明,ASPP2表达下调可以通过调控β-catenin依赖性的ZEB1来促进肿瘤的侵袭及迁移。但ASPP1在结直肠癌(CRC)中的作用尚不清楚。

研究人员通过分析TCGA的数据,结合CRC细胞系的体外实验及体内的肺转移实验,同时通过含有临床病理参数信息的CRC患者组织芯片来研究ASPP1在CRC中的表达水平及功能。

研究人员发现在CRC中,ASPP1缺乏能够增强肿瘤的迁移及侵袭能力。敲除ASPP1可以通过介导NF-κB信号通路激活Snail2的表达,进而诱导EMT(上皮-间质转化)的发生,而在RAS突变的CRC中,该过程会进一步加剧。

综上研究结果表明,ASPP1可能是结直肠癌治疗的一个重要的预后因素,NF-κB抑制剂或可为ASPP1缺乏的CRC患者的肿瘤转移提供新的治疗策略。

原始出处:

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (7)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=2013309, encodeId=445920133098c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jun 18 04:20:23 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685544, encodeId=5a4c168554445, content=<a href='/topic/show?id=69571454573' target=_blank style='color:#2F92EE;'>#PP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14545, encryptionId=69571454573, topicName=PP1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f1028217817, createdName=ms9651749636653578, createdTime=Wed Jun 10 11:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961981, encodeId=1716196198186, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Jan 18 23:20:23 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453374, encodeId=00e014533e499, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531592, encodeId=5cd1153159220, content=<a href='/topic/show?id=770e5e9457' target=_blank style='color:#2F92EE;'>#Death#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5794, encryptionId=770e5e9457, topicName=Death)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e312278742, createdName=cy0328, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587717, encodeId=76d6158e717e1, content=<a href='/topic/show?id=82fd2886ff' target=_blank style='color:#2F92EE;'>#ASPP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2886, encryptionId=82fd2886ff, topicName=ASPP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=602917558288, createdName=makuansheng, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871687, encodeId=902418e168742, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Nov 30 15:20:23 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=2013309, encodeId=445920133098c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jun 18 04:20:23 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685544, encodeId=5a4c168554445, content=<a href='/topic/show?id=69571454573' target=_blank style='color:#2F92EE;'>#PP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14545, encryptionId=69571454573, topicName=PP1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f1028217817, createdName=ms9651749636653578, createdTime=Wed Jun 10 11:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961981, encodeId=1716196198186, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Jan 18 23:20:23 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453374, encodeId=00e014533e499, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531592, encodeId=5cd1153159220, content=<a href='/topic/show?id=770e5e9457' target=_blank style='color:#2F92EE;'>#Death#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5794, encryptionId=770e5e9457, topicName=Death)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e312278742, createdName=cy0328, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587717, encodeId=76d6158e717e1, content=<a href='/topic/show?id=82fd2886ff' target=_blank style='color:#2F92EE;'>#ASPP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2886, encryptionId=82fd2886ff, topicName=ASPP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=602917558288, createdName=makuansheng, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871687, encodeId=902418e168742, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Nov 30 15:20:23 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
  3. [GetPortalCommentsPageByObjectIdResponse(id=2013309, encodeId=445920133098c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jun 18 04:20:23 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685544, encodeId=5a4c168554445, content=<a href='/topic/show?id=69571454573' target=_blank style='color:#2F92EE;'>#PP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14545, encryptionId=69571454573, topicName=PP1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f1028217817, createdName=ms9651749636653578, createdTime=Wed Jun 10 11:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961981, encodeId=1716196198186, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Jan 18 23:20:23 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453374, encodeId=00e014533e499, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531592, encodeId=5cd1153159220, content=<a href='/topic/show?id=770e5e9457' target=_blank style='color:#2F92EE;'>#Death#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5794, encryptionId=770e5e9457, topicName=Death)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e312278742, createdName=cy0328, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587717, encodeId=76d6158e717e1, content=<a href='/topic/show?id=82fd2886ff' target=_blank style='color:#2F92EE;'>#ASPP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2886, encryptionId=82fd2886ff, topicName=ASPP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=602917558288, createdName=makuansheng, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871687, encodeId=902418e168742, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Nov 30 15:20:23 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2021-01-18 docwu2019
  4. [GetPortalCommentsPageByObjectIdResponse(id=2013309, encodeId=445920133098c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jun 18 04:20:23 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685544, encodeId=5a4c168554445, content=<a href='/topic/show?id=69571454573' target=_blank style='color:#2F92EE;'>#PP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14545, encryptionId=69571454573, topicName=PP1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f1028217817, createdName=ms9651749636653578, createdTime=Wed Jun 10 11:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961981, encodeId=1716196198186, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Jan 18 23:20:23 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453374, encodeId=00e014533e499, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531592, encodeId=5cd1153159220, content=<a href='/topic/show?id=770e5e9457' target=_blank style='color:#2F92EE;'>#Death#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5794, encryptionId=770e5e9457, topicName=Death)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e312278742, createdName=cy0328, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587717, encodeId=76d6158e717e1, content=<a href='/topic/show?id=82fd2886ff' target=_blank style='color:#2F92EE;'>#ASPP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2886, encryptionId=82fd2886ff, topicName=ASPP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=602917558288, createdName=makuansheng, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871687, encodeId=902418e168742, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Nov 30 15:20:23 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=2013309, encodeId=445920133098c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jun 18 04:20:23 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685544, encodeId=5a4c168554445, content=<a href='/topic/show?id=69571454573' target=_blank style='color:#2F92EE;'>#PP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14545, encryptionId=69571454573, topicName=PP1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f1028217817, createdName=ms9651749636653578, createdTime=Wed Jun 10 11:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961981, encodeId=1716196198186, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Jan 18 23:20:23 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453374, encodeId=00e014533e499, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531592, encodeId=5cd1153159220, content=<a href='/topic/show?id=770e5e9457' target=_blank style='color:#2F92EE;'>#Death#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5794, encryptionId=770e5e9457, topicName=Death)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e312278742, createdName=cy0328, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587717, encodeId=76d6158e717e1, content=<a href='/topic/show?id=82fd2886ff' target=_blank style='color:#2F92EE;'>#ASPP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2886, encryptionId=82fd2886ff, topicName=ASPP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=602917558288, createdName=makuansheng, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871687, encodeId=902418e168742, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Nov 30 15:20:23 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2020-04-23 cy0328
  6. [GetPortalCommentsPageByObjectIdResponse(id=2013309, encodeId=445920133098c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jun 18 04:20:23 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685544, encodeId=5a4c168554445, content=<a href='/topic/show?id=69571454573' target=_blank style='color:#2F92EE;'>#PP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14545, encryptionId=69571454573, topicName=PP1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f1028217817, createdName=ms9651749636653578, createdTime=Wed Jun 10 11:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961981, encodeId=1716196198186, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Jan 18 23:20:23 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453374, encodeId=00e014533e499, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531592, encodeId=5cd1153159220, content=<a href='/topic/show?id=770e5e9457' target=_blank style='color:#2F92EE;'>#Death#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5794, encryptionId=770e5e9457, topicName=Death)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e312278742, createdName=cy0328, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587717, encodeId=76d6158e717e1, content=<a href='/topic/show?id=82fd2886ff' target=_blank style='color:#2F92EE;'>#ASPP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2886, encryptionId=82fd2886ff, topicName=ASPP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=602917558288, createdName=makuansheng, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871687, encodeId=902418e168742, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Nov 30 15:20:23 CST 2020, time=2020-11-30, status=1, ipAttribution=)]
    2020-04-23 makuansheng
  7. [GetPortalCommentsPageByObjectIdResponse(id=2013309, encodeId=445920133098c, content=<a href='/topic/show?id=7d69598468' target=_blank style='color:#2F92EE;'>#Dis#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=36, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5984, encryptionId=7d69598468, topicName=Dis)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=c689267, createdName=cmj8wellington, createdTime=Thu Jun 18 04:20:23 CST 2020, time=2020-06-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1685544, encodeId=5a4c168554445, content=<a href='/topic/show?id=69571454573' target=_blank style='color:#2F92EE;'>#PP1#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=14545, encryptionId=69571454573, topicName=PP1)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4f1028217817, createdName=ms9651749636653578, createdTime=Wed Jun 10 11:20:23 CST 2020, time=2020-06-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1961981, encodeId=1716196198186, content=<a href='/topic/show?id=dbe6445416' target=_blank style='color:#2F92EE;'>#CEL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4454, encryptionId=dbe6445416, topicName=CEL)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a12645, createdName=docwu2019, createdTime=Mon Jan 18 23:20:23 CST 2021, time=2021-01-18, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1453374, encodeId=00e014533e499, content=<a href='/topic/show?id=098ee8679ad' target=_blank style='color:#2F92EE;'>#结直肠#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=78679, encryptionId=098ee8679ad, topicName=结直肠)], attachment=null, authenticateStatus=null, createdAvatar=/v1.0.0/img/user_icon.png, createdBy=9ace5575596, createdName=crystal0564, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1531592, encodeId=5cd1153159220, content=<a href='/topic/show?id=770e5e9457' target=_blank style='color:#2F92EE;'>#Death#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=5794, encryptionId=770e5e9457, topicName=Death)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=32e312278742, createdName=cy0328, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1587717, encodeId=76d6158e717e1, content=<a href='/topic/show?id=82fd2886ff' target=_blank style='color:#2F92EE;'>#ASPP#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=51, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2886, encryptionId=82fd2886ff, topicName=ASPP)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=602917558288, createdName=makuansheng, createdTime=Thu Apr 23 13:20:23 CST 2020, time=2020-04-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1871687, encodeId=902418e168742, content=<a href='/topic/show?id=fd764459a8' target=_blank style='color:#2F92EE;'>#Cell#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=34, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=4459, encryptionId=fd764459a8, topicName=Cell)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=524d95, createdName=zhaozhouchifen, createdTime=Mon Nov 30 15:20:23 CST 2020, time=2020-11-30, status=1, ipAttribution=)]

相关资讯

Radiology:结直肠癌肺转移射频消融后的3年生存率有多高?

尽管射频消融术(RFA)已被广泛用于结直肠癌(CRC)肺转移的治疗中,但其与手术切除相比的效能尚不明确。

DCR:计步手环在预测结直肠癌手术患者术后并发症的风险中的作用

本项研究使用可穿戴技术(计步手环)来监测结直肠手术前的活动水平,以评估术前活动对术后结局的影响。

DCR:新辅助放化疗和全直肠系膜切除术后,辅助化学疗法不能改善2期或3期直肠癌患者的无复发生存率

目前关于局部晚期直肠癌的治疗指南建议患者先行新辅助放化疗,然后行全直肠系膜切除和辅助化疗。但是行辅助化疗的肿瘤学益处尚未得到一致证实。

Cell:张泽民研究组揭示结直肠癌靶向髓系细胞的免疫治疗机理

免疫检查点抑制剂(Immune checkpoint blockade, ICB)能够破坏肿瘤细胞对免疫监视的逃逸,极大地改变肿瘤病人的治疗模式 【1】。尽管基于免疫检查点开发的抑制剂药物,如PD-1

Cell Rep: 肠道细菌或能通过刺激免疫细胞对抗结直肠癌

来自法国Collège大学微生物系的一项研究证明,肠道菌群失衡会促进结直肠癌的发作。

辉瑞114亿美元收购的BRAF抑制剂Braftovi,获FDA批准与西妥昔单抗联合治疗结直肠癌

FDA批准将辉瑞(Ffizer)的BRAF抑制剂Braftovi与礼来(Eli Lilly)的EGFR单抗Erbitux联合,用于二线治疗结直肠癌(CRC)。